Inhibition of NO-medicate Responses by 7-ethoxyresorufin, a Substrate and Competitive Inhibitor of Cytochrome P450

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1996 May 1

PMID 8733576

Citations 3

Authors

C G Li

M J Rand

Affiliations

Soon will be listed here.

Abstract

1. The effects of 7-ethoxyresorufin (7-ER), which is a substrate for and competitive inhibitor of cytochrome P450, were studied on responses to nitric oxide (NO), the NO donors sodium nitroprusside (SNP) and glyceryl trinitrate (GTN), acetylcholine-induced endothelium-dependent relaxations of rat and rabbit aortic rings and nitrergic nerve stimulation-induced relaxations of rat anococcygeus muscles. 2. In rat and rabbit aortic rings, 7-ER (2 microM) inhibited the relaxations to acetylcholine in endothelium-intact preparations and the relaxant action of NO in endothelium-denuded preparations. Relaxant responses to SNP and GTN were inhibited by 7-ER in the rat but not rabbit aortic rings. However, the relaxant actions of papaverine and 8-bromo-cyclic GMP were not affected by 7-ER. 3. In rat anococcygeus muscles, 7ER (2 microM) inhibited the relaxant action of NO, but relaxations elicited by nitrergic nerve stimulation were only partly inhibited by a higher concentration of 7-ER (10 microM). 4. After inhibition by 7-ER, superoxide dismutase (100 u ml-1) restored NO-induced relaxations of the rat aortic rings, but not acetylcholine-, SNP or GTN-induced relaxations, and restored NO- and nitrergic nerve stimulation-induced relaxations of anococcygeus muscles. 5. Another cytochrome P450 inhibitor, troleandomycin (10-30 microM), had no effect on NO- or acetylcholine-induced relaxations of rat aortic rings and NO- or nitrergic nerve stimulation-induced relaxations of anococcygeus muscles. However, resorufin, an analogue of 7-ER, inhibited responses to acetylcholine, NO and GTN in rat aortic rings. 6. The results suggest that 7-ER inhibited responses to NO and nitrergic nerve stimulation through generation of superoxide radicals. However, an additional mechanism may be involved in the reduction in acetylcholine-induced response in aortic rings. 7. A 7-ER sensitive P450 system may be involved in the bioactivation of GTN and SNP in rat aortic rings, but not in rabbit aorta or rat anococcygeus muscles.

Citing Articles

Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450 and K+.

Drummond G, Selemidis S, Cocks T Br J Pharmacol. 2000; 129(4):811-9.

PMID: 10683206 PMC: 1571894. DOI: 10.1038/sj.bjp.0703107.

Effects of pyrogallol, hydroquinone and duroquinone on responses to nitrergic nerve stimulation and NO in the rat anococcygeus muscle.

La M, Rand M Br J Pharmacol. 1999; 126(1):342-8.

PMID: 10051154 PMC: 1565785. DOI: 10.1038/sj.bjp.0702277.

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II.

Pagano P, Clark J, Clark S, Callis G, Quinn M Proc Natl Acad Sci U S A. 1998; 94(26):14483-8.

PMID: 9405639 PMC: 25029. DOI: 10.1073/pnas.94.26.14483.

References

Gillespie J . The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br J Pharmacol. 1972; 45(3):404-16. PMC: 1666160. DOI: 10.1111/j.1476-5381.1972.tb08097.x. View

Rand M, Li C . Nitric oxide as a neurotransmitter in peripheral nerves: nature of transmitter and mechanism of transmission. Annu Rev Physiol. 1995; 57:659-82. DOI: 10.1146/annurev.ph.57.030195.003303. View

Yeates R, Schmid M, Leitold M . Antagonism of glycerol trinitrate activity by an inhibitor of glutathione S-transferase. Biochem Pharmacol. 1989; 38(11):1749-53. DOI: 10.1016/0006-2952(89)90408-5. View

Li C, Rand M . Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin Exp Pharmacol Physiol. 1989; 16(12):933-8. DOI: 10.1111/j.1440-1681.1989.tb02404.x. View

Oyekan A, McGiff J, Quilley J . Cytochrome P-450-dependent vasodilator responses to arachidonic acid in the isolated, perfused kidney of the rat. Circ Res. 1991; 68(4):958-65. DOI: 10.1161/01.res.68.4.958. View

Bredt D, Hwang P, Glatt C, Lowenstein C, Reed R, Snyder S . Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991; 351(6329):714-8. DOI: 10.1038/351714a0. View

Moncada S, Palmer R, Higgs E . Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43(2):109-42. View

Bates J, Baker M, Guerra Jr R, Harrison D . Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol. 1991; 42 Suppl:S157-65. DOI: 10.1016/0006-2952(91)90406-u. View

Hobbs A, Tucker J, Gibson A . Differentiation by hydroquinone of relaxations induced by exogenous and endogenous nitrates in non-vascular smooth muscle: role of superoxide anions. Br J Pharmacol. 1991; 104(3):645-50. PMC: 1908243. DOI: 10.1111/j.1476-5381.1991.tb12483.x. View

10.

Liu Z, Brien J, Marks G, Mclaughlin B, Nakatsu K . Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relaxation of aorta. Eur J Pharmacol. 1992; 211(1):129-32. DOI: 10.1016/0014-2999(92)90275-9. View

11.

Schroder H . Cytochrome P-450 mediates bioactivation of organic nitrates. J Pharmacol Exp Ther. 1992; 262(1):298-302. View

12.

White K, Marletta M . Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry. 1992; 31(29):6627-31. DOI: 10.1021/bi00144a001. View

13.

Kowaluk E, Seth P, Fung H . Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther. 1992; 262(3):916-22. View

14.

Boucher J, Genet A, Vadon S, Delaforge M, Henry Y, Mansuy D . Cytochrome P450 catalyzes the oxidation of N omega-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline. Biochem Biophys Res Commun. 1992; 187(2):880-6. DOI: 10.1016/0006-291x(92)91279-y. View

15.

Barbier A, Lefebvre R . Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur J Pharmacol. 1992; 219(2):331-4. DOI: 10.1016/0014-2999(92)90315-u. View

16.

Klatt P, Schmidt K, Mayer B . Brain nitric oxide synthase is a haemoprotein. Biochem J. 1992; 288 ( Pt 1):15-7. PMC: 1132072. DOI: 10.1042/bj2880015. View

17.

Fulton D, McGiff J, Quilley J . Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol. 1992; 107(3):722-5. PMC: 1907785. DOI: 10.1111/j.1476-5381.1992.tb14513.x. View

18.

Nelson D, Kamataki T, Waxman D, Guengerich F, Estabrook R, Feyereisen R . The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993; 12(1):1-51. DOI: 10.1089/dna.1993.12.1. View

19.

Wink D, Osawa Y, Darbyshire J, Jones C, Eshenaur S, Nims R . Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch Biochem Biophys. 1993; 300(1):115-23. DOI: 10.1006/abbi.1993.1016. View

20.

McDonald B, Bennett B . Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450. Biochem Pharmacol. 1993; 45(1):268-70. DOI: 10.1016/0006-2952(93)90403-j. View